Europe Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Country and Growth Forecast, 2024 - 2031

The Europe Huntington's Disease Treatment Market would witness market growth of 8.8% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Huntington's Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $51,954.4 Thousands by 2031. The UK market is exhibiting a CAGR of 7.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.7% during (2024 - 2031).

Disease-modifying therapies aim to alter the course of Huntington’s Disease by targeting the underlying genetic and biological mechanisms driving neurodegeneration. The goal of antisense oligonucleotide (ASO) and RNA interference (RNAi) therapy is to decrease the generation of mutant huntingtin protein (mHTT), which is neurotoxic. These therapies slow disease progression by lowering mHTT levels in the brain. Also, CRISPR/Cas9 and other gene editing approaches can potentially edit the mutant HTT gene directly, correcting the genetic mutation responsible for HD or modifying its expression.

Supportive care strategies are integral to managing the complex needs of HD patients and addressing the disease’s broader impact on their lives. HD patients benefit from care provided by multidisciplinary teams, including neurologists, genetic counselors, psychiatrists, physical therapists, occupational therapists, and social workers. This comprehensive approach addresses HD’s diverse medical, psychological, and social aspects.

The UK develops specialized healthcare services and infrastructure to meet the needs of individuals with HD. This includes HD clinics staffed by multidisciplinary teams of neurologists, genetic counselors, psychologists, and social workers. These clinics provide comprehensive care and support tailored to the complex needs of HD patients and their families. As per Brain Research UK, around 7,000 people are living with Huntington’s disease (HD) in the UK. In conclusion, the prevalence of Huntington’s disease in the region is driving the market's growth.

Free Valuable Insights: The Global Huntington's Disease Treatment Market will Hit USD 805.1 Million by 2031, at a CAGR of 9.0%

Based on Drug Type, the market is segmented into Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Store & Retail Pharmacies, and Online Pharmacies. Based on Age, the market is segmented into Below 50 years and Above 50 years. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Bausch Health Companies, Inc.
• Teva Pharmaceutical Industries Ltd.
• Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
• Hikma Pharmaceuticals PLC
• Takeda Pharmaceutical Company Limited
• Sun Pharmaceutical Industries Ltd.
• Dr.Reddy’s Laboratories Ltd.
• Neurocrine Biosciences Inc.
• Pfizer, Inc.
• F.Hoffmann-La Roche Ltd.

Europe Huntington’s Disease Treatment Market Report Segmentation

By Drug Type

• Approved Drugs
  • Tetrabenazine
  • Deutetrabenazine
• Offlabel Drugs

By Distribution Channel

• Hospital Pharmacies
• Drug Store & Retail Pharmacies
• Online Pharmacies

By Age

• Below 50 years
• Above 50 years

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Huntington’s Disease Treatment Market, by Drug Type
1.4.2 Europe Huntington’s Disease Treatment Market, by Distribution Channel
1.4.3 Europe Huntington’s Disease Treatment Market, by Age
1.4.4 Europe Huntington’s Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Huntington’s Disease Treatment Market by Drug Type
4.1 Europe Approved Drugs Market by Country
4.2 Europe Huntington’s Disease Treatment Market by Approved Drugs Type
4.2.1 Europe Tetrabenazine Market by Country
4.2.2 Europe Deutetrabenazine Market by Country
4.3 Europe Offlabel Drugs Market by Country

Chapter 5. Europe Huntington’s Disease Treatment Market by Distribution Channel
5.1 Europe Hospital Pharmacies Market by Country
5.2 Europe Drug Store & Retail Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country

Chapter 6. Europe Huntington’s Disease Treatment Market by Age
6.1 Europe Below 50 years Market by Country
6.2 Europe Above 50 years Market by Country

Chapter 7. Europe Huntington’s Disease Treatment Market by Country
7.1 Germany Huntington’s Disease Treatment Market
7.1.1 Germany Huntington’s Disease Treatment Market by Drug Type
7.1.1.1 Germany Huntington’s Disease Treatment Market by Approved Drugs Type
7.1.2 Germany Huntington’s Disease Treatment Market by Distribution Channel
7.1.3 Germany Huntington’s Disease Treatment Market by Age
7.2 UK Huntington’s Disease Treatment Market
7.2.1 UK Huntington’s Disease Treatment Market by Drug Type
7.2.1.1 UK Huntington’s Disease Treatment Market by Approved Drugs Type
7.2.2 UK Huntington’s Disease Treatment Market by Distribution Channel
7.2.3 UK Huntington’s Disease Treatment Market by Age
7.3 France Huntington’s Disease Treatment Market
7.3.1 France Huntington’s Disease Treatment Market by Drug Type
7.3.1.1 France Huntington’s Disease Treatment Market by Approved Drugs Type
7.3.2 France Huntington’s Disease Treatment Market by Distribution Channel
7.3.3 France Huntington’s Disease Treatment Market by Age
7.4 Russia Huntington’s Disease Treatment Market
7.4.1 Russia Huntington’s Disease Treatment Market by Drug Type
7.4.1.1 Russia Huntington’s Disease Treatment Market by Approved Drugs Type
7.4.2 Russia Huntington’s Disease Treatment Market by Distribution Channel
7.4.3 Russia Huntington’s Disease Treatment Market by Age
7.5 Spain Huntington’s Disease Treatment Market
7.5.1 Spain Huntington’s Disease Treatment Market by Drug Type
7.5.1.1 Spain Huntington’s Disease Treatment Market by Approved Drugs Type
7.5.2 Spain Huntington’s Disease Treatment Market by Distribution Channel
7.5.3 Spain Huntington’s Disease Treatment Market by Age
7.6 Italy Huntington’s Disease Treatment Market
7.6.1 Italy Huntington’s Disease Treatment Market by Drug Type
7.6.1.1 Italy Huntington’s Disease Treatment Market by Approved Drugs Type
7.6.2 Italy Huntington’s Disease Treatment Market by Distribution Channel
7.6.3 Italy Huntington’s Disease Treatment Market by Age
7.7 Rest of Europe Huntington’s Disease Treatment Market
7.7.1 Rest of Europe Huntington’s Disease Treatment Market by Drug Type
7.7.1.1 Rest of Europe Huntington’s Disease Treatment Market by Approved Drugs Type
7.7.2 Rest of Europe Huntington’s Disease Treatment Market by Distribution Channel
7.7.3 Rest of Europe Huntington’s Disease Treatment Market by Age

Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sun Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Hikma Pharmaceuticals PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
8.5.1 Company Overview
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Neurocrine Biosciences Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.9 Pfizer, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional & Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. F. Hoffmann-La Roche Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 Europe Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 2 Europe Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 3 Europe Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 4 Europe Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 5 Europe Approved Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 6 Europe Approved Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 7 Europe Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 8 Europe Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 9 Europe Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 10 Europe Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 11 Europe Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 12 Europe Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 13 Europe Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 14 Europe Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 15 Europe Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 16 Europe Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 17 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 18 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 19 Europe Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 20 Europe Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 21 Europe Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 22 Europe Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 23 Europe Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 24 Europe Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 25 Europe Below 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 26 Europe Below 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 27 Europe Above 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 28 Europe Above 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 29 Europe Huntington’s Disease Treatment Market by Country, 2020 - 2023, USD Thousands
TABLE 30 Europe Huntington’s Disease Treatment Market by Country, 2024 - 2031, USD Thousands
TABLE 31 Germany Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 32 Germany Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 33 Germany Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 34 Germany Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 35 Germany Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 36 Germany Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 37 Germany Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 38 Germany Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 39 Germany Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 40 Germany Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 41 UK Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 42 UK Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 43 UK Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 44 UK Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 45 UK Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 46 UK Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 47 UK Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 48 UK Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 49 UK Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 50 UK Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 51 France Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 52 France Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 53 France Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 54 France Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 55 France Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 56 France Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 57 France Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 58 France Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 59 France Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 60 France Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 61 Russia Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 62 Russia Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 63 Russia Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 64 Russia Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 65 Russia Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 66 Russia Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 67 Russia Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 68 Russia Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 69 Russia Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 70 Russia Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 71 Spain Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 72 Spain Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 73 Spain Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 74 Spain Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 75 Spain Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 76 Spain Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 77 Spain Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 78 Spain Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 79 Spain Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 80 Spain Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 81 Italy Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 82 Italy Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 83 Italy Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 84 Italy Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 85 Italy Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 86 Italy Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 87 Italy Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 88 Italy Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 89 Italy Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 90 Italy Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 91 Rest of Europe Huntington’s Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 92 Rest of Europe Huntington’s Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 93 Rest of Europe Huntington’s Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 94 Rest of Europe Huntington’s Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 95 Rest of Europe Huntington’s Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 96 Rest of Europe Huntington’s Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 97 Rest of Europe Huntington’s Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 98 Rest of Europe Huntington’s Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 99 Rest of Europe Huntington’s Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 100 Rest of Europe Huntington’s Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 101 Key Information – Dr. Reddy’s Laboratories Ltd.
TABLE 102 Key Information – Takeda Pharmaceutical Company Limited
TABLE 103 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 104 Key Information – Hikma Pharmaceuticals PLC
TABLE 105 Key Information – Camber Pharmaceuticals, Inc.
TABLE 106 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 107 key information – Bausch Health Companies, Inc.
TABLE 108 Key Information – Neurocrine Biosciences Inc.
TABLE 109 Key Information – Pfizer, Inc.
TABLE 110 Key Information – F. Hoffmann-La Roche Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Huntington’s Disease Treatment Market, 2020 - 2031, USD Thousands
FIG 3 Key Factors Impacting Huntington’s Disease Treatment Market
FIG 4 Porter’s Five Forces Analysis – Huntington's Disease Treatment Market
FIG 5 Europe Huntington’s Disease Treatment Market share by Drug Type, 2023
FIG 6 Europe Huntington’s Disease Treatment Market share by Drug Type, 2031
FIG 7 Europe Huntington’s Disease Treatment Market by Drug Type, 2020 - 2031, USD Thousands
FIG 8 Europe Huntington’s Disease Treatment Market share by Distribution Channel, 2023
FIG 9 Europe Huntington’s Disease Treatment Market share by Distribution Channel, 2031
FIG 10 Europe Huntington’s Disease Treatment Market by Drug Type, 2020 - 2031, USD Thousands
FIG 11 Europe Huntington’s Disease Treatment Market share by Age, 2023
FIG 12 Europe Huntington’s Disease Treatment Market share by Age, 2031
FIG 13 Europe Huntington’s Disease Treatment Market by Age, 2020 - 2031, USD Thousands
FIG 14 Europe Huntington’s Disease Treatment Market share by Country, 2023
FIG 15 Europe Huntington’s Disease Treatment Market share by Country, 2031
FIG 16 Europe Huntington’s Disease Treatment Market by Drug Type, 2020 - 2031, USD Thousands
FIG 17 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 18 SWOT Analysis:Takeda Pharmaceutical Company Limited
FIG 19 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 20 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 21 SWOT Analysis: Bausch Health Companies, Inc.
FIG 22 SWOT Analysis: Pfizer, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.